Algometrx Inc.
Washington, DC
- UEI
- K4GWRFENNUG3
- CAGE
- 7HXC0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2844 28th St NW, Washington, DC 20008, USA
- Website
- algometrx.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Children's Research Institute | P50FD007965 | $49,896 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Rhaeos, Inc. | Chicago, IL | — |
| Medical Device R&D | San Francisco, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Hemex Health Inc. | Portland, OR | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| A M E C | — | 541330 Engineering Services |
| Rush River Research Corporation | Ellsworth, WI | 541330 Engineering Services |
About the company
Algometrx Inc. is a woman-owned small business corporate entity headquartered in Washington, DC, focused on developing innovative medical technology solutions. The company was spun out of Children's National Hospital to commercialize novel medical diagnostic technologies, specializing in non-invasive neurological assessment devices. Through its federal grant awards, Algometrx provides advanced medical research and technological development services to federal health-related agencies, with a particular emphasis on creating objective physiological measurement tools for complex medical conditions.
The company has secured two significant federal grant awards from prominent health research agencies, demonstrating its specialized capabilities in medical technology development. The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Algometrx a grant (R43AR082160) to develop a novel technology for measuring systemic lupus erythematosus (SLE) disease activity, utilizing a non-invasive neuroselective electrical stimulation and infrared pupillometry approach. Similarly, the National Cancer Institute provided a grant (R43CA275524) for developing an objective physiological measure to assess vincristine-induced peripheral neuropathy in pediatric patients. Additionally, Algometrx has a sub-grant award from Children's Research Institute for the Alliance for Pediatric Device Innovation, further highlighting its collaborative approach to medical technology research. These grants focus on creating innovative diagnostic tools that can objectively measure complex neurological and inflammatory conditions, with potential applications in early disease detection, treatment optimization, and clinical trial endpoint development.
Quick answers
Is Algometrx Inc. registered in SAM.gov?
Yes. Algometrx Inc.'s SAM.gov registration is active through April 3, 2027.
What is Algometrx Inc.'s most recent federal award?
Algometrx Inc.'s most recent federal grant award is Development of a novel technology for the determination of a physiologic phenotype in patients with systemic lupus… (R43AR082160), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 22, 2022.
On GovTribe
See Algometrx Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors